Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

ClinicalTrials.gov ID: NCT07284758

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07284758. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 20, 2026, 4:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, open-label, single-arm, multicenter study to assess the antimyeloma activity and further characterize the safety, tolerability, PK, and PD of cemsidomide in combination with dexamethasone in participants with relapsed/refractory multiple myeloma (r/r MM).

Study identification

NCT ID
NCT07284758
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
C4 Therapeutics, Inc.
Industry
Enrollment
100 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 18, 2026 (Actual)
Primary completion
Mar 2030 (Estimated)
Completion
Mar 2030 (Estimated)
Last update posted
Oct 30, 2026

2026 – 2030

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Clearview Cancer Institute Huntsville Alabama 35805 Recruiting
Mayo Clinic - Arizona Phoenix Arizona 85054 Recruiting
HonorHealth Scottsdale Arizona 85258 Recruiting
City of Hope Duarte California 91010 Recruiting
Berenson Cancer Center West Hollywood California 90069 Recruiting
Mayo Clinic - Florida Jacksonville Florida 32224 Recruiting
Winship Cancer Institute, Emory University Atlanta Georgia 30322 Recruiting
Indiana University Health Indianapolis Indiana 46202 Recruiting
University of Iowa Iowa City Iowa 52242 Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts 02114 Not yet recruiting
Dana Farber Cancer Institute Boston Massachusetts 02114 Not yet recruiting
Massachusetts General Hospital Boston Massachusetts 02114 Recruiting
University of Michigan Ann Arbor Michigan 48109 Recruiting
Karmanos Cancer Institute Detroit Michigan 48201 Recruiting
START Midwest Grand Rapids Michigan 49546 Recruiting
Mayo Clinic - Minnesota Rochester Minnesota 55905 Recruiting
Washington University/Siteman Cancer Center St Louis Missouri 63108 Recruiting
University of Nebraska Medical Center Omaha Nebraska 68198 Recruiting
The Tisch Cancer Institute/Mount Sinai New York New York 10029 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
UNC Hospitals Adult Oncology Clinics Chapel Hill North Carolina 27514 Recruiting
Tennessee Oncology Nashville Tennessee 37203 Recruiting
START San Antonio San Antonio Texas 78229 Recruiting
University of Wisconsin - Carbone Cancer Center Madison Wisconsin 53792 Recruiting
MCW-Clinical Cancer Center at Froedtert Hospital Campus Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07284758, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 30, 2026 · Synced Nov 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.